Comparison of topical tofacitinib and 0.1% hypochlorous acid in a murine atopic dermatitis model.

about

Comparison of topical tofacitinib and 0.1% hypochlorous acid in a murine atopic dermatitis model.

Item

http://www.wikidata.org/entity/Q55517994

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Comparison of topical tofaciti ...... urine atopic dermatitis model.

@en

Comparison of topical tofaciti ...... urine atopic dermatitis model.

@nl

type

Item

label

Comparison of topical tofaciti ...... urine atopic dermatitis model.

@en

Comparison of topical tofaciti ...... urine atopic dermatitis model.

@nl

prefLabel

Comparison of topical tofaciti ...... urine atopic dermatitis model.

@en

Comparison of topical tofaciti ...... urine atopic dermatitis model.

@nl

P1476

Comparison of topical tofaciti ...... urine atopic dermatitis model.

@en

P2093

Jenny Wilzopolski

http://www.w3.org/2001/XMLSchema#string

Sarah Ehling

http://www.w3.org/2001/XMLSchema#string

Tomoki Fukuyama

http://www.w3.org/2001/XMLSchema#string

P2860

Cellular and molecular immunologic mechanisms in patients with atopic dermatitis.

Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report.

Atopic dermatitis: a practice parameter update 2012.

Sensory neurons and circuits mediating itch.

Effects of Hovenia dulcis Thunb. extract and methyl vanillate on atopic dermatitis-like skin lesions and TNF-α/IFN-γ-induced chemokines production in HaCaT cells.

Antipruritic hydrogel for the treatment of atopic dermatitis: an open-label pilot study.

The epithelial cell-derived atopic dermatitis cytokine TSLP activates neurons to induce itch.

AWD 12-281, a highly selective phosphodiesterase 4 inhibitor, is effective in the prevention and treatment of inflammatory reactions in a model of allergic dermatitis.

Topically Administered Janus-Kinase Inhibitors Tofacitinib and Oclacitinib Display Impressive Antipruritic and Anti-Inflammatory Responses in a Model of Allergic Dermatitis.

Janus kinase inhibitors display broad anti-itch properties: A possible link through the TRPV1 receptor.

P2888

s40360-018-0232-3

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S40360-018-0232-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Wolfgang Bäumer

P577

2018-07-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1105289768

http://www.w3.org/2001/XMLSchema#string

P698

29970189

http://www.w3.org/2001/XMLSchema#string

P932

6029395

http://www.w3.org/2001/XMLSchema#string